Marcus Trescothick Joins Somerset In Fight Against Skin Cancer
Marcus Trescothick joined his Somerset team mates to take part in skin screenings, highlighting the need for regular skin cancer checks.
The screenings, organised by national skin cancer charity, Melanoma UK, have been welcome by the club who regularly check players for signs of skin cancer.
Speaking from the County Ground, Somerset’s head of science and medicine, Jamie Thorpe commented:
“Skin cancer is something that is an issue that we have to consider in cricket given the demands of the sport and the environment we have to play in.
Our link with Melanoma UK over the last three years has been invaluable to the club.
We have had exceptional support in ensuring that our players have regular screenings, which in some cases has led to potentially life saving interventions.
We hope this link can continue for many years and are fully supportive of what Melanoma UK is trying to achieve in raising awareness of this issue.
We thank them for their support and would highly recommend that others look to seek regular screenings with their local GPs and dermatologists”.
Gill Nuttall, CEO of Melanoma UK added:
“It is good to see cricket taking such a proactive role in the early detection and prevention of melanoma.
Andy Flower has been one of our ambassadors since his own brush with melanoma and is very supportive of our work.
We are delighted to be able to spread the word in this way and look forward to seeing more clubs following in the footsteps of Somerset”.
Skin Cancer Facts
Recent statistics show that the number of people diagnosed with malignant melanoma, the most serious form of skin cancer, is five times higher than it was 40 years ago.
Malignant melanoma is now the fifth most common cancer in the UK and more than 2,000 people die from the disease each year.
Across the country, the number of people admitted to hospital for skin cancer increased by 41 per cent in five years.
According to a study, conducted by researchers at Public Health England, admissions for both non melanoma skin cancer and malignant melanoma rose ‘significantly’ from 87,685 in 2007 to 123,808 in 2011.
The rise in popularity of sunbeds and sunlamps may have also contributed to the increased rates.